CN104357581A - Standard sample with molecular characteristics of nucleic acid of Ebola viruses and preparation method thereof - Google Patents

Standard sample with molecular characteristics of nucleic acid of Ebola viruses and preparation method thereof Download PDF

Info

Publication number
CN104357581A
CN104357581A CN201410597668.9A CN201410597668A CN104357581A CN 104357581 A CN104357581 A CN 104357581A CN 201410597668 A CN201410597668 A CN 201410597668A CN 104357581 A CN104357581 A CN 104357581A
Authority
CN
China
Prior art keywords
standard sample
sequence
plasmid
preparation
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410597668.9A
Other languages
Chinese (zh)
Other versions
CN104357581B (en
Inventor
薛芳
李云峰
崔丽伟
赵亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410597668.9A priority Critical patent/CN104357581B/en
Publication of CN104357581A publication Critical patent/CN104357581A/en
Application granted granted Critical
Publication of CN104357581B publication Critical patent/CN104357581B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a preparation method for a standard sample with molecular characteristics of nucleic acids of Ebola viruses. The standard sample with the molecular characteristics of the nucleic acids of the Ebola viruses is prepared through steps of synthetizing sequences, cloning carriers, connecting target fragments with the carriers, transforming plasmids, extracting, freeze-drying and preserving recombinant plasmids, and the like. According to the invention, the standard sample which contains the sequence information of virus characteristics is prepared, and through the standard sample, Ebola viruses and the content level of Ebola viruses in the sample can be analyzed. The standard sample provided by the invention has the advantages of good uniformity, high stability and good purity, and the standard sample can be stored for a long term; the preparation method is simple in process, and the standard sample can be provided for detection research, medical research and the like of the Ebola viruses to realize the comparison of different laboratory results, so that the quality control in a laboratory is ensured; and at the same time, the standard sample is also provided for enterprises, such as inspection and quarantine institutions and import and export trade enterprises for quick and accurate detection of the Ebola viruses.

Description

Ebola virus nucleic acid molecule characteristic standard sample and preparation method thereof
Technical field
The present invention relates to a kind of Ebola virus nucleic acid molecule characteristic standard sample and preparation method thereof, belong to biology field.
Background technology
On May 14 nineteen ninety-five (lunar calendar April 15), Zaire finds rare transmissible disease Ebola.Ebola (Ebola), be used to the generic term that address a group belongs to fiber Viraceae Ebola virus subordinate several viral, Ebola virus hemorrhagic fever can be caused, suffer from this disease and can cause people in extremely, comprise several symptoms in various degree, comprise nausea,vomiting,diarrhea, colour of skin change, sore all over, body internal hemorrhage, external hemorrhage, fever etc., the infected's symptom is very similar to the Marburg virus being all fiber Viraceae.This virus is named (this state is once called as Zaire) with the Ebola river of African cd, and this place is close to the clan of the first explosion, and the Congo is still the location of nearest four outbursts, comprises once being very popular of in May, 2005.
Ebola virus, Biosafety grade is 4 grades (acquired immune deficiency syndrome (AIDS) is 3 grades, and SARS is 3 grades, and the larger protection of progression is stricter).Virus latency can reach 2 to 21 days, but usually only has 5 days to 10 days.In these viral epidemic situations of Africa outburst in 2014, Ebola's epidemic situation the most serious since this has record has caused 932 people dead.
At present, the diagnostic method of Ebola virus is primarily of diagnostic techniquess such as virus purification, agarose immunodiffusion technique, molecular biology.In recent years, along with the development of Protocols in Molecular Biology, the advantage that real-time fluorescence PCR technology is quick with it, responsive, specificity is good accounts for very large advantage, cause the concern of numerous investigator, but existing molecular Biological Detection test kit mostly is company and designs positive control according to document, does not have unified standard.Along with the increase of foreign trade, the inspection process time limit shortens, and is difficult to the quality control ensureing laboratory.
Summary of the invention
For the problems referred to above, the present invention develops a kind of Ebola virus nucleic acid molecule characteristic standard sample, can be used for positive control when characteristic sequence detects, to ensure the tractability of detected result.Concrete technical scheme is as follows.
The preparation method of Ebola virus nucleic acid molecule characteristic standard sample of the present invention, mainly comprises the steps:
1) synthesize virus sequence, its sequence is as described in Sequence NO.1: and a T7 promotor is increased before every section of sequence;
2) composition sequence flush end be cloned into plasmid and cut qualification and glue purification by enzyme;
3) ligation of object fragment and carrier;
4) by competence Bacterial Transformation plasmid;
5) recombinant plasmid extracts;
6) spectrophotometer method is adopted to carry out quality examination to recombinant plasmid;
7) choose purity and all qualified recombinant plasmid of integrity, solution is mixed, and again measure concentration and purity, then carry out packing freeze-drying, the standard model prepared is placed in-80 DEG C of Refrigerator stores.
The qualification of recombinant plasmid is also comprised: namely from the bacterium liquid that step 4) obtains, get 1-3 bacterium colony in step described in the preparation method of above-mentioned Ebola virus nucleic acid molecule characteristic standard sample, be inoculated in the LB substratum containing ammonia benzyl and cultivate, extract plasmid, then pcr amplification is carried out, PCR primer carries out agarose gel electrophoresis, screening positive clone.
Determining nucleic acid sequence and sequence comparative analysis is also comprised: the bacterium being about to be accredited as through PCR positive recombinant plasmid is checked order and carries out homology analysis in step described in the preparation method of above-mentioned Ebola virus nucleic acid molecule characteristic standard sample.
The Ebola virus nucleic acid molecule characteristic standard sample that the present invention obtains, is the recombinant vectors of the nucleotide sequence containing Sequence NO.1.And described recombinant vectors is plasmid.
Further, above-mentioned steps 2) concrete steps of described clone and glue purification are: sequence flush end are cloned in pUC19 plasmid; Enzyme is cut qualification and is selected ecor I and xbai carries out enzyme as the cloning site of plasmid vector and cuts, 37 DEG C, reaction 1-2h, and reaction system is DNA 16 μ L, 10X buffer 2 μ L, ecorI 1 μ L, xbai 1 μ L; Digestion products, through 1% agarose gel electrophoresis, cuts required fragment, and glue reclaims purifying.
Further, above-mentioned steps 3) the ligation concrete steps of described object fragment and carrier are: condition is 16 DEG C, reaction 16h, reaction system is: step 2) the purified product 1 μ L that obtains, composition sequence X μ L: the mol ratio of itself and carrier is 3 ~ 20:1, T4 Ligase 1 μ L, 10X Ligase solution 1 μ L, adds deionized water polishing to 10 μ L.
Further, above-mentioned steps 4) concrete steps of described competence Bacterial Transformation plasmid are: competence bacterium are added in the aseptic Eppendorf pipe of precooling, get the ligation liquid that step 3) obtains, be added in the pipe containing DH5 α competence bacterium, light mixing, leaves standstill 30min, 42 DEG C of heat shock 90s on ice, do not rock pipe, leave standstill 5min on ice, add not containing the LB substratum of ammonia benzyl, 37 DEG C, 225rpm, cultivates 1h and obtains conversion fluid; Get on LB solid medium that conversion fluid coats containing ammonia benzyl, be inverted for 37 DEG C and cultivate 16h.
The present invention is based on the RNA sequence of virus and the basis of cDNA sequence complementation, DNA synthetic technology is utilized to synthesize the nucleic acids characteristic sequence of virus, be cloned in plasmid vector, prepared a kind of standard model comprising virus characteristic sequence information, be suitable for this virus and contents level in analytic sample; Standard model good uniformity provided by the invention, stability is strong, can preserve for a long time, purity is good, and preparation method's process is simple, standard model can be provided for Ebola virus detect delay, medical research etc., to realize the result comparison of different experiments room, thus ensure the quality control in laboratory; Simultaneously also for the enterprises such as inspection and quarantine mechanism, foreign trade realize providing standard model to the quick and precisely detection of Ebola virus.
Accompanying drawing explanation
Fig. 1 plasmid enzyme restriction electrophorogram, Fig. 2 recombinant plasmid sequencer map, Fig. 3 sequence alignment is reported.
Embodiment
Experiment material: pUC19 plasmid, agarose, restriction enzyme ecor I and xbai, T4 Ligase test kit, gel purification kit, DH5 α bacterial strain, LB substratum are purchased from the precious biotechnology company limited in Dalian, and Wizard PlusSV Minipreps DNA Purification System is purchased from promega company.
Embodiment 1: the preparation of standard model
1. Synthetic sequence: Using 7.0 downloaded from GenBank sequences publicly available software Clone Manager, homology analysis and primer matching analysis to determine the proposed synthesis of viral sequences: CTA CTA CCA CAA TAT CGG AAC TTT TCT TTC TCA TTG AAA GAG AAA GAG TTG AAT GTA GGT AGA ACC TTC GGA AAA TTG CCT TAT CCG ACT CGC AAT GTT CAA ACA CTT TGT GAA GCT CTG TTA GCT GAT GGT CTT GCT AAA GCA TTT CCT AGC AAT ATG ATG GTA GTT ACG GAA CGT GAG CAA AAA GAA AGC TTA TTG CAT CAA GCA TCA TGG CAC CAC ACA AGT GAT GAT TTT GGT GAA CAT GCC ACA GTT AGA GGG AGT AGC TTT GTA ACT GAT TTA GAG AAA TAC AAT CTT GCA TTT AGA TAT GAG TTT ACA GCA CCT TTT ATA GAA TAT TGC AAC CGT TGC TAT GGT GTT AAG AAT GTT TTT AAT TGG ATG CAT TAT ACA ATC CCA CAG TGT TAT ATG CAT GTC AGT GAT TAT TAT AAT CCA CCA CAT AAC CTC ACA CTG GAG AAT CGA GAC AAC CCC CCC GAA GGG CCT AGT TCA TAC AGG GGT CAT ATG GGA GG, sequence of the synthetic commissioned completed; for the convenience of the viral nucleic acid sequences in vitro transcribed into RNA, prior to each addition of a T7 promoter sequence, the sequence 20bp: TAA TAC GAC TCA CTA TAG GG;
2. composition sequence flush end be cloned into pUC19 plasmid and cut qualification and glue purification by enzyme: sequence clone being entered in pUC19 plasmid, analyzing through sequence restriction enzyme site, selecting ecor I and xbai carries out enzyme as the cloning site of plasmid vector and cuts, as shown in Figure 1,37 DEG C, reaction 1-2h, reaction system is as follows:
Digestion products, through 1% agarose gel electrophoresis, cuts required fragment, carries out glue reclaim purifying according to Takara company gel purification kit specification sheets;
3. the ligation of object fragment and carrier
Carry out ligation after glue purification, 16 DEG C, reaction 16h, system is as follows:
4. the preparation of competence bacterium
The frozen DH5 α bacterium of picking is inoculated in LB culture medium flat plate, be inverted overnight incubation for 37 DEG C, choose single colony inoculation to spend the night in 37 DEG C of 250rpm shaking culture in 5mL LB substratum, switching 1mL overnight culture enters in 100mL LB liquid nutrient medium cultivates 2-3h in 37 DEG C, makes it to enter logarithmic phase OD 600be about 0.3,4 DEG C, the centrifugal 10min of 4,000g, reclaim bacterium, remove most substratum, add 1 × TSS Buffer of 10mL precooling, resuspended bacterium, be distributed into 200 μ L/ and manage, be placed in-70 DEG C for subsequent use;
5. by competence Bacterial Transformation plasmid: DH5 α competent cell takes out from-70 DEG C of refrigerators, is placed in thawed on ice, gets 100 μ L and is added in the aseptic 1.5mL Eppendorf pipe of precooling.Get the above-mentioned ligation liquid of 10 μ L, be added in the pipe containing DH5 α competence bacterium, gently mix, leave standstill 30min on ice.42 DEG C of heat shock 90s, do not rock pipe.Leave standstill 5min on ice, add 0.9mL not containing the LB substratum of ammonia benzyl, 37 DEG C, 225rpm, cultivate 1h.Get on LB solid medium that 100-300 μ L conversion fluid coats containing ammonia benzyl (100 μ g/mL), be inverted for 37 DEG C and cultivate 16h;
6. the qualification of recombinant plasmid
Get 1-3 bacterium colony, be inoculated in 5mL containing ammonia benzyl LB substratum in, 37 DEG C, 225rpm, cultivate 12h, extract plasmid, and with for template, carry out pcr amplification with universal primer M13, PCR primer carries out agarose gel electrophoresis, screening positive clone;
7. determining nucleic acid sequence and sequence alignment analysis
The bacterium being accredited as positive recombinant plasmid through PCR send Takara company to check order, as shown in Figure 2; Sequencing result Clone Manager 7.0 software carries out sequence homology analysis qualification, and as shown in Figure 3, consistence is 100%;
8. the extraction of recombinant plasmid
Adopt Wizard PlusSV Minipreps DNA Purification System, the bacterium liquid getting 1-10mL incubated overnight moves in 10mL centrifuge tube, the centrifugal 15min of 3,000g, abandons supernatant, being inverted on filter paper makes raffinate stream clean, add the resuspended solution of 250 μ L cell in the bacterial sediment collected gently to mix, complete resuspended bacterium, moves to 1.5mL Eppendorf and manages by re-suspension liquid, add 250 μ L cell pyrolysis liquids more in the tube, mixing 4-6 time of turning upside down; Add 10 μ L alkaline phosphatase enzyme solution, mixing 4-6 time of turning upside down, room temperature leaves standstill 5min; Add 350 μ L neutralizers, mixing 4-6 time of turning upside down, the centrifugal 10min of room temperature 12,000g; Centrifugal column puts into collection tube, centrifugal supernatant is transferred in centrifugal column, room temperature 12, the centrifugal 1min of 000g, discards centrifugal rear liquid, is reentered into by centrifugal column in collection tube, the washing lotion that 750 μ L have added ethanol is added centrifugal column, the centrifugal 1min of room temperature 12,000g, discards centrifugal rear liquid, add 250 μ L washing lotions and repeat above-mentioned steps, the centrifugal 2min of room temperature 12,000g, is transferred in the Eppendorf pipe of an aseptic 1.5ml by centrifugal column, add the rnase-free deionized water of 20-30 μ L sterilizing, place 2-3min, the centrifugal 1min of room temperature 12,000g; Discard centrifugal column, reclaim the plasmid DNA of purifying ,-20 DEG C of preservations;
9. quality examination
Adopt the absorbancy of spectrophotometer method test dna under 260 nm and 280 nm, to evaluate the quality of DNA.The content that the results are shown in Table 1, DNA recombinant plasmid is 2.061 μ g, and purity meets the requirements;
Table 1 recombinant plasmid content and purity testing result (mass unit: ug)
10. sample packing
Choose purity and all qualified recombinant plasmid of integrity, solution is mixed, measure concentration and purity again, adjustment strength of solution is worth 10.000 μ g/mL, packing freeze-drying (condition: sample is positioned over pre-freeze 24h in-20 DEG C of refrigerators is carried out by 2 μ g/ pipes, ensure that sample is thoroughly freezing, after pre-freeze is terminated, fast sample is placed in the sample tray of Freeze Drying Equipment (SIM company FD5508 type), keep vacuum tightness between 30 ~ 40 mtorr, vacuum-drying 24h, is prepared into lyophilized powder sample.), the standard model prepared is placed in-80 DEG C of Refrigerator stores.
Embodiment 2: the uniformity testing of standard model
Randomly draw sample according to random sampling and carry out analysis of Uniformity:
1. homogeneity bottle
Randomly draw 1 bottle, after adding 200 μ L deionized waters, get three parts, every part of 50 μ L, are numbered 101-103, survey three times, the results are shown in Table 2 for every part; Three groups of qualitative datas are done variance analysis, and variance is neat, p=0.58>0.05, quality, without significant difference, meets uniformity requirement, and standard deviation is 0.0007.Purity, all about 1.80, meets purity requirement.
Homogeneity test result (mass unit: μ g) in table 2 bottle
2. homogeneity bottle
Extract 20 bottles by simple random sampling method, numbering 201-220, survey 3 times for every bottle.Measuring sequence: for the first time, 201 → 220; For the second time, 220 → 201; For the third time, odd number 201 → 219 → even number 202 → 220, the results are shown in Table 3; 20 groups of quality and purity data are done variance analysis, and variance is neat, p=0.92>0.05, content, without significant difference, meets uniformity requirement, and its standard deviation is 0.0007.Purity, all about 1.80, meets purity requirement.
Homogeneity test result (mass unit: μ g) between table 3 bottle
Embodiment 3: the stability test of standard model
Randomly draw sample according to random sampling and carry out stability analysis:
1. short-term stability
Randomly draw freeze-drying sample respectively at-20 DEG C, 0 DEG C, 4 DEG C, 25 DEG C, under 37 DEG C of conditions, place 2 weeks.Place 8 bottles at each temperature, totally 40 bottles, totally 40 bottles, number from 301-350, survey 3 inferior qualities for every bottle.With reference to GB/T 15000.3-2008 to the statistical study requirement of sample stability, SPSS 20.0 software is adopted to carry out variance analysis to data, inspection level p<0.05 is for there being notable difference;
5 groups of data (table 4) are done variance analysis, obvious significant difference is had between group, compare between each group further, no difference of science of statistics between-20 DEG C, 0 DEG C and 4 DEG C of groups, no difference of science of statistics between 25 DEG C and 37 DEG C, and-20 DEG C, 0 DEG C with 4 DEG C three groups with 25 DEG C, 37 DEG C two groups phase mutual significant differences.
Table 4 short-term stability detected result (mass unit: ug)
2. permanent stability
Randomly draw a collection of 45 bottles be first placed on-80 DEG C at, according to the timed interval take out under-20 DEG C of conditions place 12,9,6,3,1 month.9 bottles are placed under each time point.Synchronos method is adopted to measure concentration.With reference to GB/T 15000.3-2008 to the statistical study requirement of sample stability, SPSS 20.0 software is adopted to carry out variance analysis, inspection level p<0.05 is for there being notable difference.
5 groups of data (table 5) are done variance analysis, without significant difference between group, meets permanent stability requirement.1 year sample quality standard of appraisal deviation (STDEV)=0.028 is placed at-20 DEG C.
Table 5 permanent stability experimental result (mass unit: ug)
Continued 5
Embodiment 4: the definite value of standard model
1. cooperate definite value
The work of standard model definite value has been participated in jointly by 7 laboratories.Ultraviolet spectrophotometry is adopted to carry out cooperation definite value.Provide 1 bottle of sample for every, point measurement in three days, measures 1 every day, amounts to 3 times.Value data is in table 6, and laboratory averaged measurements is in table 7.
Table 6 laboratory measurements table look-up (mass unit: ug)
Table 7 laboratory average measurements
2. uncertainty combination
The component of uncertainty comprises ununiformity error u1+ stability error between bottle (-20 DEG C/1 year) u2+ replicate measurement error u3, cooperation definite value error u4.Overall uncertainty equals the evolution of each partial uncertainty sum of squares.
The partial uncertainty source of standard model is in table 8.Composite Seismogram is in table 9.
As calculated, expanded uncertainty U=0.048 μ g, k=2.
The uncertain component value of table 8
Table 9 Composite Seismogram
Replicate measurement error Cooperation definite value error Composite Seismogram
0.001 0.021 0.024
Definite value: 2.06 μ g, expanded uncertainty U=0.048 μ g, k=2.
Definite value result shows: the reagent that 1, preparation adopts meets requirement; 2, blending process is reasonable; 3, testing method meets the demands.
The above; be only the present invention's preferably embodiment; but protection scope of the present invention is not limited thereto; anyly be familiar with those skilled in the art in the technical scope that the present invention discloses; be equal to according to technical scheme of the present invention and inventive concept thereof and replace or change, all should be encompassed within protection scope of the present invention.
SEQUENCE LISTING
 
<110> Xue Fang
 
<120> Ebola virus nucleic acid molecule characteristic standard sample and preparation method thereof
 
<130> 2014
 
<160> 2
 
<170> PatentIn version 3.3
 
<210> 1
<211> 500
<212> DNA
<213> Sequence NO.1
 
<400> 1
ctactaccac aatatcggaa cttttctttc tcattgaaag agaaagagtt gaatgtaggt 60
 
agaaccttcg gaaaattgcc ttatccgact cgcaatgttc aaacactttg tgaagctctg 120
 
ttagctgatg gtcttgctaa agcatttcct agcaatatga tggtagttac ggaacgtgag 180
 
caaaaagaaa gcttattgca tcaagcatca tggcaccaca caagtgatga ttttggtgaa 240
 
catgccacag ttagagggag tagctttgta actgatttag agaaatacaa tcttgcattt 300
 
agatatgagt ttacagcacc ttttatagaa tattgcaacc gttgctatgg tgttaagaat 360
 
gtttttaatt ggatgcatta tacaatccca cagtgttata tgcatgtcag tgattattat 420
 
aatccaccac ataacctcac actggagaat cgagacaacc cccccgaagg gcctagttca 480
 
tacaggggtc atatgggagg 500
 
 
<210> 2
<211> 20
<212> DNA
<213> T7
 
<400> 2
taatacgact cactataggg 20

Claims (8)

1. the preparation method of Ebola virus nucleic acid molecule characteristic standard sample, is characterized in that, comprise the steps:
1) synthesize virus sequence, its sequence is as described in Sequence NO.1: and a T7 promotor is increased before every section of sequence;
2) composition sequence flush end be cloned into plasmid and cut qualification and glue purification by enzyme;
3) ligation of object fragment and carrier;
4) by competence Bacterial Transformation plasmid;
5) recombinant plasmid extracts;
6) spectrophotometer method is adopted to carry out quality examination to recombinant plasmid;
7) choose purity and all qualified recombinant plasmid of integrity, solution is mixed, and again measure concentration and purity, then carry out packing freeze-drying, the standard model prepared is placed in-80 DEG C of Refrigerator stores.
2. the preparation method of Ebola virus nucleic acid molecule characteristic standard sample according to claim 1, it is characterized in that, described step also comprises the qualification of recombinant plasmid: from the bacterium liquid that step 4) obtains, get 1-3 bacterium colony, be inoculated in the LB substratum containing ammonia benzyl and cultivate, extract plasmid, carry out pcr amplification, PCR primer carries out agarose gel electrophoresis, screening positive clone.
3. the preparation method of Ebola virus nucleic acid molecule characteristic standard sample according to claim 2, it is characterized in that, described step also comprises determining nucleic acid sequence and sequence comparative analysis: checked order by the bacterium being accredited as positive recombinant plasmid through PCR and carry out homology analysis.
4.. the Ebola virus nucleic acid molecule characteristic standard sample prepared by method described in claim 1, the recombinant vectors of the nucleotide sequence namely containing Sequence NO.1.
5. Ebola virus nucleic acid molecule characteristic standard sample according to claim 4, it is characterized in that, described recombinant vectors is plasmid.
6. the preparation method of standard model according to claim 1, is characterized in that, step 2) concrete steps of described clone and purifying are: sequence flush end are cloned in pUC19 plasmid; Enzyme is cut qualification and is selected ecor I and xbai carries out enzyme as the cloning site of plasmid vector and cuts, 37 DEG C, reaction 1-2h, and reaction system is DNA 16 μ L, 10X buffer 2 μ L, ecor I 1 μ L, xbai 1 μ L; Digestion products, through 1% agarose gel electrophoresis, cuts required fragment, and glue reclaims purifying.
7. the preparation method of standard model according to claim 1, it is characterized in that, described in step 3), the ligation concrete steps of object fragment and carrier are: condition is 16 DEG C, reaction 16h, reaction system is: step 2) the purified product 1 μ L that obtains, composition sequence X μ L: the mol ratio of itself and carrier is 3 ~ 20:1, T4 Ligase 1 μ L, 10X Ligase solution 1 μ L, adds deionized water polishing to 10 μ L.
8. the preparation method of standard model according to claim 1, is characterized in that, described in step 4), the concrete steps of competence Bacterial Transformation plasmid are: be added to by competence bacterium in the aseptic Eppendorf pipe of precooling, get the ligation liquid that step 3) obtains, be added in the pipe containing DH5 α competence bacterium, gently mix, leave standstill 30min on ice, 42 DEG C of heat shock 90s, do not rock pipe, leave standstill 5min on ice, add not containing the LB substratum of ammonia benzyl, 37 DEG C, 225rpm, cultivates 1h and obtains conversion fluid; Get on LB solid medium that conversion fluid coats containing ammonia benzyl, be inverted for 37 DEG C and cultivate 16h.
CN201410597668.9A 2014-10-30 2014-10-30 Ebola virus nucleic acid molecules characteristic standard sample and preparation method thereof Expired - Fee Related CN104357581B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410597668.9A CN104357581B (en) 2014-10-30 2014-10-30 Ebola virus nucleic acid molecules characteristic standard sample and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410597668.9A CN104357581B (en) 2014-10-30 2014-10-30 Ebola virus nucleic acid molecules characteristic standard sample and preparation method thereof

Publications (2)

Publication Number Publication Date
CN104357581A true CN104357581A (en) 2015-02-18
CN104357581B CN104357581B (en) 2016-08-24

Family

ID=52524887

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410597668.9A Expired - Fee Related CN104357581B (en) 2014-10-30 2014-10-30 Ebola virus nucleic acid molecules characteristic standard sample and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104357581B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3310368A4 (en) * 2015-06-19 2018-12-19 Seracare Life Sciences Inc. Sindbis control virus
CN110669793A (en) * 2019-10-15 2020-01-10 中国科学院武汉病毒研究所 Method for preparing lentiviral particle packaging EBOVRNA as EBOV nucleic acid detection positive reference substance
CN111850149A (en) * 2020-08-06 2020-10-30 广州海关技术中心 Vibrio parahaemolyticus nucleic acid detection plasmid DNA reference sample, preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102140533A (en) * 2010-12-24 2011-08-03 中国检验检疫科学研究院 Marburg and Ebola dual-virus fluorescent quantitative PCR (Polymerase Chain Reaction) detection method and system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102140533A (en) * 2010-12-24 2011-08-03 中国检验检疫科学研究院 Marburg and Ebola dual-virus fluorescent quantitative PCR (Polymerase Chain Reaction) detection method and system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王雪敏等: "埃博拉病毒科特迪瓦型核蛋白的原核表达及纯化", 《中国人兽共患病学报》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3310368A4 (en) * 2015-06-19 2018-12-19 Seracare Life Sciences Inc. Sindbis control virus
CN110669793A (en) * 2019-10-15 2020-01-10 中国科学院武汉病毒研究所 Method for preparing lentiviral particle packaging EBOVRNA as EBOV nucleic acid detection positive reference substance
CN111850149A (en) * 2020-08-06 2020-10-30 广州海关技术中心 Vibrio parahaemolyticus nucleic acid detection plasmid DNA reference sample, preparation method and application thereof

Also Published As

Publication number Publication date
CN104357581B (en) 2016-08-24

Similar Documents

Publication Publication Date Title
Kerur et al. Genetic characterization of Indian peste des petits ruminants virus (PPRV) by sequencing and phylogenetic analysis of fusion protein and nucleoprotein gene segments
Saren et al. A snapshot of viral evolution from genome analysis of the tectiviridae family
CN109652357B (en) Mycoplasma bovis mutant strain with growth defect under cell co-culture and application thereof
CN109680079A (en) Detect RPA primer, probe, kit and the method for vibrio parahemolyticus
CN103421906B (en) Composition and method for detecting drug resistance of staphylococcus aureus
CN111549182A (en) Probe and kit for detecting SARS-CoV-2
CN104357581A (en) Standard sample with molecular characteristics of nucleic acid of Ebola viruses and preparation method thereof
CN112301154A (en) RDA method and kit for rapidly detecting respiratory syncytial virus
CN111118219A (en) RDA method and kit for rapidly detecting influenza A virus
CN104388584A (en) Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof
CN103146846A (en) Single standard product-based four-color fluorogenic quantitative PCR (Polymerase Chain Reaction) method and kit
CN104404167A (en) Chikungunya virus nucleic acid molecule characteristic standard sample and its preparation method
Wang et al. Unique viral capsid assembly protein gene (g20) of cyanophages in the floodwater of a Japanese paddy field
CN104404168A (en) Crimean-Congo hemorrhagic fever virus nucleic acid molecule characteristic standard sample and its preparation method
CN102660777A (en) Method for constructing suppression subtractive hybridization (SSH) library of oryza rufipogon threatened by bacterial blight germs
CN104388586A (en) Dengue hemorrhagic fever virus I nucleic acid molecular characteristic standard sample and preparation method thereof
CN101824482B (en) Detection kit for vibrio cholerae O1 group and detection method thereof
CN112301153B (en) RDA method and kit for rapidly detecting Canine Coronavirus (CCV)
CN104388583A (en) Lassa fever virus nucleic acid molecular characteristic standard sample and preparation method thereof
CN112301156B (en) RDA method and kit for rapidly detecting human adenovirus
CN114958835A (en) Combination product and kit for detecting bacterial rice blight bacteria
CN104388585A (en) Dengue hemorrhagic fever virus II nucleic acid molecular characteristic standard sample and preparation method thereof
CN102304500B (en) Thermus siphoviridae phage 4 (TSP4) DNA helicase and polynucleotide coding same
CN104962561A (en) RNA aptamer and detection method for enzymatic cGAMP generation amount detection
CN104531861A (en) Molecular detection method of enterobacter sakazakii and application of molecular detection method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160824

Termination date: 20161030